Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group)

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 3, 2011, Pages 348-357

  Kuo, Chin Chi ^a   Wu, Vin Cent ^a   Huang, Kuo How ^a   Wang, So Mong ^a   Chang, Chin Chen ^a   Lu, Ching Chu ^a   Yang, Wei Shun ^b   Tsai, Ching Wei ^a   Lai, Chun Fu ^a   Lee, Tzong Yann ^c   Lin, Wei Chou ^a   Wu, Ming Shou ^a   Lin, Yen Hung ^a   Chu, Tzong Shinn ^a   Lin, Chien Yu ^c   Chang, Hung Wei ^a   Wang, Wei Jei ^b   Kao, Tze Wah ^a   Chueh, Shih Chieh ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

Author keywords

Aldosterone renin ratio; Chinese ethnicity; demography; primary aldosteronism

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM; SPIRONOLACTONE;

ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; AGE; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE PRODUCING ADENOMA; ALDOSTERONE URINE LEVEL; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRAIN HEMORRHAGE; CAUCASIAN; CHINESE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; EVALUATION; FEMALE; FOLLOW UP; GENDER; HEART RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; IDIOPATHIC HYPERALDOSTERONISM; INCIDENTALOMA; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; MEDICAL PARAMETERS; MEDICAL RECORD REVIEW; NEPHROLITHIASIS; OBSERVATIONAL STUDY; PARALYSIS; PATIENT CODING; POLYMERASE CHAIN REACTION; POTASSIUM BLOOD LEVEL; RACE; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; SEIZURE; SODIUM EXCRETION; TRANSTUBULAR POTASSIUM GRADIENT;

ADENOMA; ALDOSTERONE; COHORT STUDIES; DEMOGRAPHY; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MASS SCREENING; PREVALENCE; REPRODUCIBILITY OF RESULTS; TAIWAN;

EID: 80052347024     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310391329     Document Type: Article

References (45)

1. Mulatero P., Stowasser M., Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004 ; 89: 1045-1050. (Pubitemid 38368386)
2. Douma S., Petidis K., Doumas M., et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008 ; 371: 1921-1926. (Pubitemid 351778191)
3. Rossi GP, Bernini G., Caliumi C., et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006 ; 48: 2293-2300. (Pubitemid 44873058)
4. Milliez P., Girerd X., Plouin PF, Blacher J., Safar ME and Mourad JJ Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005 ; 45: 1243-1248. (Pubitemid 40523144)
5. Conn JW Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955 ; 45: 3-17.
6. Loh KC, Koay ES, Khaw MC, Emmanuel SC and Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000 ; 85: 2854-2859. (Pubitemid 32269163)
7. Omura M., Sasano H., Saito J., Yamaguchi K., Kakuta Y. and Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 2006 ; 29: 883-889. (Pubitemid 46062119)
8. Ma JT, Wang C., Lam KS, et al. Fifty cases of primary hyperaldosteronism in Hong Kong Chinese with a high frequency of periodic paralysis. Evaluation of techniques for tumour localisation. Q J Med 1986 ; 61: 1021-1037. (Pubitemid 17212513)
9. Huang YY, Hsu BR and Tsai JS Paralytic myopathy - a leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab 1996 ; 81: 4038-4041. (Pubitemid 26380414)
10. Wu VC, Chueh SC, Chang HW, et al. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. Q J Med 2008 ; 101: 13-22.
11. Wu VC, Chang HW, Liu KL, et al. Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests. Am J Hypertens 2009 ; 22: 821-827.
12. Wu VC, Chueh SC, Chang HW, et al. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 2009 ; 54: 665-673.
13. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM and Hollenberg JP The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008 ; 61: 1234-1240.
14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003 ; 289: 2560-2572. (Pubitemid 37430158)
15. Vidt DG Hypertensive crises: emergencies and urgencies. J Clin Hypertens (Greenwich) 2004 ; 6: 520-525.
16. Martin JF, Higashiama E., Garcia E., Luizon MR and Cipullo JP Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol 2004 ; 83: 131-6 ; 25-30.
17. Yen RF, Wu VC, Liu KL, et al. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med 2009 ; 50: 1631-1637.
18. Levey AS, Bosch JP, Lewis JB, Greene T., Rogers N. and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 ; 130: 461-470. (Pubitemid 29135798)
19. Levey AS, Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003 ; 139: 137-147.
20. West ML, Marsden PA, Richardson RM, Zettle RM and Halperin ML New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab 1986 ; 12: 234-238. (Pubitemid 16010103)
21. Chang HW, Chu TS, Huang HY, et al. Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction. J Clin Endocrinol Metab 2007 ; 92: 1863-1870.
22. Liao CH, Chueh SC, Lai MK, Hsiao PJ and Chen J. Laparoscopic adrenalectomy for potentially malignant adrenal tumors greater than 5 centimeters. J Clin Endocrinol Metab 2006 ; 91: 3080-3083. (Pubitemid 44271759)
23. Aiba M., Suzuki H., Kageyama K., et al. Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa. Am J Pathol 1981 ; 103: 404-410. (Pubitemid 11064743)
24. Omura M., Sasano H., Fujiwara T., Yamaguchi K. and Nishikawa T. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metab Clin Exp 2002 ; 51: 350-355. (Pubitemid 34232637)
25. Novitsky YW, Kercher KW, Rosen MJ, Cobb WS, Jyothinagaram S. and Heniford BT Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery 2005 ; 138: 1009-1016 ; discussion 16-17.
26. Rossi GP, Belfiore A., Bernini G., et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007 ; 50: 424-431. (Pubitemid 47205795)
27. Schwartz GL and Turner ST Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005 ; 51: 386-394. (Pubitemid 40175809)
28. Jonsson JR, Klemm SA, Tunny TJ, Stowasser M. and Gordon RD A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun 1995 ; 207: 565-571.
29. Su FH, Cheng SH, Li CY, et al. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 2007 ; 25: 8085-8090.
30. Walz MK, Gwosdz R., Levin SL, et al. Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia. World J Surg 2008 ; 32: 847-853.
31. Hiramatsu K., Yamada T., Yukimura Y., et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 1981 ; 141: 1589-1593. (Pubitemid 12234064)
32. Sartori M., Calo LA, Mascagna V., et al. Aldosterone and refractory hypertension: a prospective cohort study. Am J Hypertens 2006 ; 19: 373-9 ; discussion 80.
33. Mosso L., Carvajal C., Gonzalez A., et al. Primary aldosteronism and hypertensive disease. Hypertension 2003 ; 42: 161-165. (Pubitemid 36944590)
34. Sechi LA, Novello M., Lapenna R., et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006 ; 295: 2638-2645. (Pubitemid 43882339)
35. Fardella CE, Mosso L., Gomez-Sanchez C., et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000 ; 85: 1863-1867. (Pubitemid 32269290)
36. Blumenfeld JD, Sealey JE, Schlussel Y., et al. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994 ; 121: 877-885.
37. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008 ; 371: 2173-2182. (Pubitemid 351890412)
38. Ribstein J., Du Cailar G., Fesler P. and Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 2005 ; 16: 1320-1325. (Pubitemid 41716516)
39. Reincke M., Rump LC, Quinkler M., et al. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 2009 ; 94: 869-875.
40. Letavernier E., Peyrard S., Amar L., Zinzindohoue F., Fiquet B. and Plouin PF Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2008 ; 26: 1816-1823.
41. Pizzolo F., Trabetti E., Guarini P., et al. Glucocorticoid remediable aldosteronism (GRA) screening in hypertensive patients from a primary care setting. J Hum Hypertens 2005 ; 19: 325-327. (Pubitemid 40514912)
42. Funder JW, Carey RM, Fardella C., et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008 ; 93: 3266-3281.
43. Young WF Jr. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003 ; 144: 2208-2213. (Pubitemid 36629868)
44. Willenberg HS, Kolentini C., Quinkler M., et al. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism. Eur J Clin Invest 2009 ; 39: 43-50.
45. Armanini D. and Fiore C. Some considerations about evolution of idiopathic primary aldosteronism. J Endocrinol Invest 2009 ; 32: 623-625.